New trial
Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuroendocrine Carcinomas
Why it was picked newest record on or before this date
The Pancreatic Cancer Research Digest
New trials, papers and changes to existing records, compiled daily from the public registries
10 items · 0 changes to existing records
New trial
European Appleby Registry for Pancreatic Cancer
Why it was picked newest record on or before this date
New trial
EUS-DFI in Solid Pancreatic Lesions
Why it was picked newest record on or before this date
New trial
Targeted Nutritional Intervention (HMB, Arginine, Glutamine) in Patients With Pancreatic Cancer
Why it was picked newest record on or before this date
New trial
A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation
Why it was picked newest record on or before this date
Also today
New trial
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer
New trial
Study Examining the Safety and Toxicity of Stereotactic Body Radiotherapy (SBRT) Followed by PCX12 Immunotherapy Delivered by Intratumoral Injection for the Treatment of Patients With Locally Advanced Pancreatic Adenocarcinoma (LAPC)
New trial
Oncolytic Virus Plus PD-1 Inhibitor to Patients With Advanced Pancreatic Cancer
New trial
A Study of MC001 in Patients With Advanced or Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) and Other Folate Receptor Alpha (FRα)-Expressing Solid Tumors
Editor’s note
Not in the data yet: changes to existing records. Status changes, newly posted results and retractions need a history of each record, which is not collected yet. Until then the digest lists new records only.
Compiled by the knowledge layer from its change log. Every headline opens the underlying record; every identifier links to its source.